Method for producing living tissue and organ
10400203 ยท 2019-09-03
Assignee
Inventors
- Xiaowen Zhao (Guangdong, CN)
- Dongfeng Zhang (Guangdong, CN)
- Wenping Zhao (Guangdong, CN)
- Junhua Cai (Guangdong, CN)
Cpc classification
B33Y10/00
PERFORMING OPERATIONS; TRANSPORTING
G06T17/10
PHYSICS
B33Y80/00
PERFORMING OPERATIONS; TRANSPORTING
C12M21/08
CHEMISTRY; METALLURGY
B33Y50/02
PERFORMING OPERATIONS; TRANSPORTING
C12M25/00
CHEMISTRY; METALLURGY
International classification
B33Y50/02
PERFORMING OPERATIONS; TRANSPORTING
B33Y80/00
PERFORMING OPERATIONS; TRANSPORTING
G06T17/10
PHYSICS
C12M3/00
CHEMISTRY; METALLURGY
C12M1/12
CHEMISTRY; METALLURGY
Abstract
A method for producing a living tissue and organ includes: collecting medical image information of a target tissue and organ, and converting the medical image information into three-dimensional image information; performing machine recognition and multiple feature comparisons on the three-dimensional image information, and generating a primary three-dimensional model according to physiological structure data of tissues and organs in a tissue and organ database and a residual profile of the target tissue and organ; generating a complete three-dimensional model by producing an internal microstructure of the primary three-dimensional model with reference to the tissue and organ database; producing a full-scale physical model based on the complete three-dimensional model by an additive manufacturing process; and performing a living cell-based tissue reconstruction in the full-scale physical model to produce a living tissue and organ.
Claims
1. A method for producing a living tissue and organ, comprising: collecting medical image information of a target tissue and organ, and converting the medical image information into three-dimensional image information; performing machine recognition and multiple feature comparisons on the three-dimensional image information, and generating a primary three-dimensional model according to physiological structure data of tissues and organs in a tissue and organ database and a residual profile of the target tissue and organ; generating a complete three-dimensional model by producing an internal microstructure of the primary three-dimensional model with reference to the tissue and organ database; producing a full-scale physical model based on the complete three-dimensional model by an additive manufacturing process; performing surface treatment on the full-scale physical model, and verifying geometrical shapes and functions of an internal three-dimensional microstructure and an appearance three-dimensional structure of the full-scale physical model; performing a medical biological test on the full-scale physical model to determine whether the full-scale physical model satisfies a medical microenvironment in which a living cell multiplies if the full-scale physical model meets a preset verification requirement for geometrical shapes and a preset verification requirement for functions; and performing a living cell-based tissue reconstruction in the full-scale physical model to produce a living tissue and organ if the full-scale physical model satisfies the medical microenvironment.
2. The method for producing a living tissue and organ according to claim 1, wherein the full-scale physical model is made of materials with biocompatibility and bioactivity.
3. The method for producing a living tissue and organ according to claim 2, wherein the materials with biocompatibility and bioactivity comprise: hydroxyapatite, polylactic acid and polylactic-co-glycolic acid.
4. The method for producing a living tissue and organ according to claim 2, wherein the producing a full-scale physical model based on the complete three-dimensional model by an additive manufacturing process comprises producing the full-scale physical model by a three dimensional (3D) printing method.
5. The method for producing a living tissue and organ according to claim 1, wherein the producing a full-scale physical model based on the complete three-dimensional model by an additive manufacturing process comprises producing the full-scale physical model by a three dimensional (3D) printing method.
6. The method for producing a living tissue and organ according to claim 1, wherein the producing an internal microstructure of the primary three-dimensional model comprises producing the internal microstructure of the primary three-dimensional model according to porosity, aperture size and shape, and structural features.
7. The method for producing a living tissue and organ according to claim 6, wherein an internal three-dimensional microstructure of the living tissue and organ comprises a set of runner systems which are mutually communicated.
8. The method for producing a living tissue and organ according to claim 1, wherein the verifying geometrical shapes and functions of an internal three-dimensional microstructure and an appearance three-dimensional structure of the full-scale physical model comprises: measuring parameters of the internal three-dimensional microstructure of the full-scale physical model, comparing the parameters with parameters of an internal three-dimensional microstructure of the target tissue and organ to obtain a comparison result, and determining whether the comparison result satisfies a preset requirement; and matching the appearance three-dimensional structure of the full-scale physical model with the residual profile of the target tissue and organ to determine whether a preset matching requirement is met.
9. The method for producing a living tissue and organ according to claim 8, wherein the internal three-dimensional microstructure of the full-scale physical model comprises micropores, and quantity, sizes, distribution and shapes of the micropores are adjustable.
10. The method for producing a living tissue and organ according to claim 9, wherein an internal three-dimensional microstructure of the living tissue and organ comprises a set of runner systems which are mutually communicated.
11. The method for producing a living tissue and organ according to claim 8, wherein the internal three-dimensional microstructure of the full-scale physical model comprises a pipeline structure, and distribution, pipe diameter and porosity of the pipeline structure are adjustable.
12. The method for producing a living tissue and organ according to claim 11, wherein an internal three-dimensional microstructure of the living tissue and organ comprises a set of runner systems which are mutually communicated.
13. The method for producing a living tissue and organ according to claim 8, wherein an internal three-dimensional microstructure of the living tissue and organ comprises a set of runner systems which are mutually communicated.
14. The method for producing a living tissue and organ according to claim 1, wherein the performing surface treatment on the full-scale physical model comprises disinfecting a surface of the full-scale physical model.
15. The method for producing a living tissue and organ according to claim 14, wherein an internal three-dimensional microstructure of the living tissue and organ comprises a set of runner systems which are mutually communicated.
16. The method for producing a living tissue and organ according to claim 1, further comprising the following step after generating the complete three-dimensional model: storing the complete three-dimensional model as a file of at least one of the following data formats: stl, stp, obj, max, 3ds, ma, vtk and igs.
17. The method for producing a living tissue and organ according to claim 16, wherein an internal three-dimensional microstructure of the living tissue and organ comprises a set of runner systems which are mutually communicated.
18. The method for producing a living tissue and organ according to claim 1, wherein the collecting medical image information of a target tissue and organ comprises: collecting medical image information of the target tissue and organ of a patient through computed tomography (CT), magnetic resonance imaging (MRI) or positron emission tomography-computed tomography (PET-CT).
Description
BRIEF DESCRIPTION OF DRAWINGS
(1)
(2)
(3)
(4)
(5)
DETAILED DESCRIPTION
(6) Embodiments of the present disclosure are described with reference to the drawings. The present disclosure is described below in combination with
(7) In S110, medical image information of a target tissue and organ is collected, and the medical image information is converted into three-dimensional image information.
(8) Optionally, the medical image information of the target tissue and organ may refer to medical image information of the target tissue and organ of a patient. Optionally, the medical image information of the target tissue and organ may be medical image information of the target tissue and organ of the patient collected through computed tomography (CT), magnetic resonance imaging (MRI) or positron emission tomography-computed tomography (PET-CT). Exemplarily,
(9) In S120, machine recognition and multiple feature comparisons are performed on the three-dimensional image information, and a primary three-dimensional model is generated according to physiological structure data of tissues and organs in a tissue and organ database and a residual profile of the target tissue and organ.
(10) Exemplarily,
(11) In S130, an internal microstructure of the primary three-dimensional model is produced with reference to the tissue and organ database to generate a complete three-dimensional model.
(12) Exemplarily,
(13) Optionally, the internal microstructure of the primary three-dimensional model is produced according to porosity, aperture size and shape, and structural features.
(14) Optionally, an internal three-dimensional microstructure of a full-scale physical model includes micropores, and quantity, sizes, distribution and shapes of the micropores are adjustable.
(15) Optionally, the internal three-dimensional microstructure of the full-scale physical model includes a pipeline structure, and distribution, pipe diameter and porosity of the pipeline structure are adjustable.
(16) Optionally, after the complete three-dimensional model is generated, the method further includes storing the complete three-dimensional model as a file of at least one of the following data formats: stl, stp, obj, max, 3ds, ma, vtk and igs.
(17) In S140, a full-scale physical model is produced based on the complete three-dimensional model by an additive manufacturing process.
(18) Optionally, the full-scale physical model is made of materials with biocompatibility and bioactivity. Optionally, the materials with biocompatibility and bioactivity may include: hydroxyapatite (HA), polylactic acid (PLA) and polylactic-co-glycolic acid (PLGA), which are not specifically limited.
(19) Optionally, the full-scale physical model is produced by using a 3D printing method in S140.
(20) In S150, surface treatment is performed on the full-scale physical model, geometrical shapes and functions of an internal three-dimensional microstructure and an appearance three-dimensional structure of the full-scale physical model are verified.
(21) Exemplarily,
(22) Optionally, the surface treatment on the full-scale physical model includes disinfecting a surface of the full-scale physical model. For example, the surface of the full-scale physical model is disinfected by using alcohol.
(23) Optionally, the geometrical shapes and functions of the internal three-dimensional microstructure and the appearance three-dimensional structure of the full-scale physical model are verified by the following steps:
(24) measuring parameters of the internal three-dimensional microstructure of the full-scale physical model, comparing the parameters with parameters of the internal three-dimensional microstructure of the target tissue and organ to obtain a comparison result, and determining whether the comparison result satisfies a preset requirement; and
(25) matching the appearance three-dimensional structure of the full-scale physical model with the residual profile of the target tissue and organ to determine whether a preset matching requirement is met.
(26) In S160, if the full-scale physical model meets a preset verification requirement, a medical biological test is performed on the full-scale physical model to determine whether the full-scale physical model satisfies a medical microenvironment in which a living cell multiplies.
(27) The living cell is cultured on the full-scale physical model. In a growth process of the living cell, the full-scale physical model will be gradually decomposed and absorbed by the living cell, and a living tissue and organ formed by living cell multiplication reproduces the configuration of the full-scale physical model.
(28) In S170, a living cell-based tissue reconstruction is performed in the full-scale physical model to produce a living tissue and organ if the full-scale physical model satisfies the medical microenvironment.
(29) Optionally, the internal three-dimensional microstructure of the living tissue and organ includes a set of runner systems which are mutually communicated.
(30) According to the method for producing a living tissue and organ proposed by the embodiment of the present disclosure, the living tissue and organ is produced rapidly; the living tissue and organ is precise in the shape of the internal microstructure, high in bionic degree, has small biological anisotropy and good medical and biological characteristics. Therefore, the method for producing a living tissue and organ proposed by the embodiment of the present disclosure fills a blank of the relevant technology and can also generate great social benefits and economic benefits.
(31) The above only describes disclosed embodiments, and does not limit the present disclosure in any form. Any amendment, change and equivalent variation made to above embodiments according to the substance of the present disclosure still belong to a protection scope of a technology of the present disclosure.
INDUSTRIAL APPLICABILITY
(32) According to the method for producing a living tissue and organ proposed by the embodiment of the present disclosure, the living tissue and organ is produced rapidly; the living tissue and organ is precise in the shape of the internal microstructure, high in bionic degree, and has small biological anisotropy and good medical and biological characteristics. Therefore, the method for producing a living tissue and organ proposed by the embodiment of the present disclosure fills a blank of the relevant technology and can also generate great social benefits and economic benefits.